New evidence
Vitamin D showed the strongest metabolic improvements in a meta-analysis of PCOS — a finding based on just 3 studies, none of which were harmful but one was neutral.
This is the first solid evidence linking vitamin D supplementation to lower fasting insulin in women with PCOS, but with only 3 studies in the analysis and mixed effect sizes, it's an early signal, not a settled conclusion.
A new meta-analysis of nutraceutical interventions for polycystic ovary syndrome found that vitamin D supplementation led to the largest reductions in fasting insulin and improvements in hormone balance (lower LH, higher SHBG). However, the evidence is still moderate in strength, the dose wasn't specified, and the effects on ovarian follicle count and menstrual bleeding were inconsistent — meaning the benefit appears real but is narrowly focused on metabolic and hormonal markers.
Where this fits in the evidence
Pillser has synthesized 3 studies on Vitamin D for Reduced Insulin Levels — overall evidence strength: Moderate.
Across 3 meta-analyses, 2 reported beneficial moderate-to-large effects of vitamin D supplementation on reducing insulin levels in patients with diabetes/prediabetes and women with PCOS, while one large meta-analysis in overweight/obese children found no significant effect. The predominant effect size among beneficial studies was mixed (moderate to large). No dose or form data were consistently reported across studies.
The study
- Meta-Analysis
- 2025-11-24
- Diabetes, obesity & metabolism
- PubMed: 41287200
- DOI: 10.1111/dom.70307
- Full study breakdown →
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.